The subject of the present invention is compounds corresponding to formula (I): ##STR00001## Wherein X, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as described herein. The invention also relates to a method for the preparation and application of said compounds as cannabinoid CB1 receptor antagonists.